Reuters logo
BRIEF-Trovagene selected as liquid biopsy provider
2016年10月4日 / 上午10点37分 / 1 年内

BRIEF-Trovagene selected as liquid biopsy provider

Oct 4 (Reuters) - Trovagene Inc

* Selected as liquid biopsy provider to participate in first large-scale precision medicine trial for patients with pancreatic cancer

* Selected by Pancreatic Cancer Action Network as liquid biopsy provider to participate in precision medicine trial Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below